Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2614092019 | Sustained-release buccal tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 2616693014 | Sustained-release buccal tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2660664019 | Sustained-release buccal tablet (qualifier value) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3671364015 | Prolonged-release buccal tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3671365019 | Prolonged-release buccal tablet (dose form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3671366018 | Extended-release buccal tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prolonged-release buccal tablet | Is a | Buccal dose form | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Is a | Buccal tablet | false | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has state of matter | Solid | false | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has dose form administration method | Administer | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has dose form transformation | No transformation | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has dose form intended site | Buccal | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has basic dose form | Tablet | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Has dose form release characteristic | Prolonged-release | true | Inferred relationship | Some | ||
| Prolonged-release buccal tablet | Is a | Oromucosal dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glyceryl trinitrate 1 mg prolonged-release buccal tablet | Has manufactured dose form | True | Prolonged-release buccal tablet | Inferred relationship | Some | |
| Glyceryl trinitrate 3 mg prolonged-release buccal tablet | Has manufactured dose form | True | Prolonged-release buccal tablet | Inferred relationship | Some | |
| Glyceryl trinitrate 5 mg prolonged-release buccal tablet | Has manufactured dose form | True | Prolonged-release buccal tablet | Inferred relationship | Some | |
| Glyceryl trinitrate 2 mg prolonged-release buccal tablet | Has manufactured dose form | True | Prolonged-release buccal tablet | Inferred relationship | Some | |
| Glyceryl trinitrate 1.5 mg prolonged-release buccal tablet | Has manufactured dose form | True | Prolonged-release buccal tablet | Inferred relationship | Some |
Reference Sets
Qualifier value foundation reference set
FHIR